8.00

1.27% 0.10

Puma Biotechnology Inc (PBYI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$7.90

Offen:

$7.9

24-Stunden-Volumen:

342.26K

Relative Volume:

1.15

Marktkapitalisierung:

$407.20M

Einnahmen:

$227.18M

Nettoeinkommen (Verlust:

$24.38M

KGV:

16.76

EPS:

0.4774

Netto-Cashflow:

$53.60M

1W Leistung:

-3.15%

1M Leistung:

+13.96%

6M Leistung:

+30.93%

1J Leistung:

+127.27%

1-Tages-Spanne:

$7.70

$8.135

1-Wochen-Bereich:

$7.67

$8.44

52-Wochen-Spanne:

$3.03

$8.44

Puma Biotechnology Inc Stock (PBYI) Company Profile

Firmenname

Puma Biotechnology Inc

Sektor

Healthcare (1096)

Branche

Biotechnology (616)

Telefon

(424) 248-6500

Adresse

10880 WILSHIRE BLVD., LOS ANGELES, CA

Mitarbeiter

179

Twitter

Nächster Verdiensttermin

2026-08-06

Neueste SEC-Einreichungen

PBYI's Discussions on Twitter

Compare PBYI vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PBYI Puma Biotechnology Inc	8.00	407.20M	227.18M	24.38M	53.60M	0.4774
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-09-28	Hochstufung	Citigroup	Neutral → Buy
2020-06-25	Fortgesetzt	BofA/Merrill	Underperform
2019-10-08	Herabstufung	Goldman	Neutral → Sell
2019-05-10	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2019-05-10	Herabstufung	Citigroup	Buy → Neutral
2019-01-17	Eingeleitet	Leerink Partners	Mkt Perform
2019-01-03	Herabstufung	Guggenheim	Buy → Neutral
2018-11-19	Hochstufung	Goldman	Sell → Neutral
2018-11-02	Herabstufung	BofA/Merrill	Buy → Underperform
2018-11-02	Herabstufung	JP Morgan	Neutral → Underweight
2018-10-01	Eingeleitet	Cantor Fitzgerald	Overweight
2018-09-17	Eingeleitet	Goldman	Sell
2018-05-11	Bestätigt	Stifel	Buy
2017-11-10	Bestätigt	Citigroup	Buy
2017-11-10	Bestätigt	RBC Capital Mkts	Sector Perform
2017-10-02	Bestätigt	Stifel	Buy
2017-09-11	Bestätigt	Credit Suisse	Outperform
2017-07-10	Fortgesetzt	Leerink Partners	Outperform
2017-06-06	Bestätigt	RBC Capital Mkts	Sector Perform
2017-05-25	Bestätigt	RBC Capital Mkts	Sector Perform
2017-03-02	Bestätigt	RBC Capital Mkts	Sector Perform

Alle ansehen

Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten

Jul 08, 2026

Puma Biotechnology’s Douglas M. Hunt sells $69,904 in shares By Investing.com - Investing.com Nigeria

Jul 08, 2026

Puma biotechnology CFO Maximo Nougues sells $77,556 in stock By Investing.com - Investing.com South Africa

Jul 08, 2026

Form 4 Puma Biotechnology Inc For: 8 July By Investing.com - Investing.com Nigeria

Jul 08, 2026

Alan Auerbach, Puma Biotechnology president and CEO, sells $364,051 By Investing.com - Investing.com Nigeria

Jul 08, 2026

Puma Biotechnology (PBYI) CEO sells 44,058 shares under 10b5-1 plan - Stock Titan

Jul 08, 2026

Puma Biotechnology (PBYI) CFO sells 9,386 shares in 10b5-1 trade - Stock Titan

Jul 08, 2026

Puma Biotechnology’s Douglas M. Hunt sells $69,904 in shares - Investing.com

Jul 08, 2026

Jul 06, 2026

Form 144 PUMA BIOTECHNOLOGY For: 6 July By Investing.com - Investing.com Nigeria

Jul 06, 2026

Puma Biotechnology highlights targeted cancer therapies as investors watch Nasdaq-listed PBYI - ad-hoc-news.de

Jul 03, 2026

Jul 02, 2026

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)July 2, 2026 - BioSpace

Jul 02, 2026

PBYI News | PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) - ChartMill

Jul 02, 2026

Jun 29, 2026

Puma Biotechnology, Inc.(NasdaqGS:PBYI) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026

Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026

Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026

Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Puma Biotechnology, Inc.(NasdaqGS:PBYI) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 28, 2026

Enterprise value to revenue forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView

Jun 28, 2026

Enterprise value to EBITDA forward of Puma Biotechnology Inc – NASDAQ:PBYI - TradingView

Jun 28, 2026

PBYI Forecast — Price Target — Prediction for 2027 - TradingView

Jun 28, 2026

Price to book forward of Puma Biotechnology Inc – NASDAQ:PBYI - TradingView

Jun 28, 2026

Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026

Jun 27, 2026

Price to sales forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView

Jun 27, 2026

Enterprise value to EBIT forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView

Jun 27, 2026

Enterprise value to EBITDA forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView

Jun 27, 2026

Jun 26, 2026

Puma Biotechnology, Inc. Actuals & Estimates (NASDAQ:PBYI) - TradingView

Jun 26, 2026

Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates - Kavout | AI

Jun 26, 2026

Jun 24, 2026

Puma Pharmaceuticals Puma Biotechnology Puma Biotechnology Puma 2019 Revenue Breast Cancer Treatment - consumerthai

Jun 24, 2026